MYPOS
23.7.2020 15:54:07 CEST | Business Wire | Press release
The European company, myPOS, specialised in offering affordable payments technology to SMEs, has launched a new series of premium cards for its customers: the myPOS Visa Platinum Metal Card and myPOS Visa Platinum Silver & Gold Card. The offering includes a range of benefits such as a LoungeKey pass to over 1000 airport business lounges worldwide, 0.1% cashback on all purchases, 10 or 15% cashback for every purchase in the myPOS online shop and myPOS physical stores in Europe, free ATM withdrawals on a monthly basis, free delivery and reissuing and more.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200723005575/en/
Christo Georgiev, myPOS Founder, said: “Currently, the Metal cards are available for individual clients only. Together with Visa, we are pioneering this space by offering the first metal card for businesses in Europe.”
The myPOS Visa Platinum Silver, Gold and Metal cards will be offered in Europe to all merchants using the myPOS platform for a monthly or annual subscription and will be in addition to myPOS’ current business card. The metal Platinum Visa card will be offered to micro and small merchants – this distinguishes the myPOS offering in Europe where prestigious metal cards are typically offered mainly to individual consumers.
While the Visa Platinum card is available in two designs – Gold and Silver, the exclusive Visa Metal card comes in brushed black metal with laser engraving and is three-times the weight of a standard card. Its metal coating keeps it protected, so it won’t get warped, cracked or damaged.
Through the new Visa Platinum cards, myPOS is enabling micro and small merchants to access premium services that they may not have previously been able to receive.
Since its official introduction in 2014, myPOS has been offering a free business card with every myPOS account as part of its unique payment acceptance solution with instant pay-out of the received funds.
About myPOS
myPOS is a fintech company serving over 100,000 business clients across the European Economic Area. The myPOS e-money accounts and payment services are provided by myPOS Europe, a UK E-Money Institution, authorised and regulated by the FCA in partnership with an EU-licensed E-Money Institution, a direct member of Visa, Mastercard, Amex, JCB, UPI and other card schemes.
myPOS was awarded the Best POS Innovation by the Merchant Payments Ecosystem in 2019 and Best B2B payments company by the Breakthrough Awards program in 2020.
myPOS headquarters are located at Level 24, The Shard, London Bridge Street, London SE1 9SG, UK.
Find out more on www.myPOS.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200723005575/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Capcom’s All-New IP PRAGMATA Surpasses One Million Units Sold in Two Days!20.4.2026 15:00:00 CEST | Press release
– Highly innovative and original gameplay earns strong reception from players around the globe – Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of PRAGMATA, the company’s all-new IP released on April 17, 2026*, have surpassed one million units. PRAGMATA is a science-fiction action-adventure game that depicts the journey of Hugh Williams and Diana, an android girl, in a near-future lunar world. A completely new IP, PRAGMATA was developed primarily by a team of younger Capcom developers, who created an innovative gameplay experience by fusing action gameplay with puzzle elements set within a distinctive world ruled over by artificial intelligence. In the absence of an established fan base or preexisting brand recognition, Capcom implemented a range of marketing initiatives—beginning with the early release of a playable demo—to communicate the unique features of the game to a wider audience. In addition, in line with the company’s multi-platform strategy, Capcom broade
Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer20.4.2026 14:30:00 CEST | Press release
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutation in either FBXW7 or PPP2R1A, platinum-resistant/refractory ovarian cancer. The FDA’s Fast Track program is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and fill an unmet medical need. Programs granted Fast Track designation benefit from more frequent communication with the FDA and, if relevant criteria are met, may be eligible for Priority Review and Accelerated Approval of a New Drug Application (NDA). Momentum Following AACR O
Data4Industry-X Empowers Industrial Organizations in Meeting Digital Product Passport Requirements20.4.2026 14:17:00 CEST | Press release
Contributing to the International Manufacturing-X Council Showcase at Hannover Messe, to improve resilience, productivity and innovation in Manufacturing Hannover Messe - Data4Industry-X, the trusted industry data space solution, builds its momentum by accelerating Digital Product Passport (DPP) compliance with trusted, secure and traceable data exchange at scale, as demonstrated at Hannover Messe April 20-24, 2026 . As theDigital Product Passport becomes a regulatory reality for manufacturing organizations, the ability to exchange data in a trusted, secure and traceable environment across the entire supply chain, in compliance with data regulations such as the Data Act, has become critical. Actively contributing to the International Manufacturing-X Council showcase, driven by LNI 4.0 association involving 16 countries, Data4Industry-X, a decentralized environment, demonstrates the use case of the DPP on the battery’s State of Health, and how the battery current capacity and performanc
Ushio Industry & Entertainment Appoints Takuya Matsumoto as President & CEO and Outlines Strategic Direction for the Next Phase20.4.2026 12:32:00 CEST | Press release
Ushio Industry & Entertainment (Ushio INE GmbH) announces the appointment of Takuya Matsumoto as President and Chief Executive Officer, marking a key milestone in the evolution of the business and its integration within the Ushio Group. With more than 20 years of experience across sales, new business development, and global operations, Takuya Matsumoto brings deep industry expertise and a strong leadership track record within Ushio. Most recently, he served as General Manager of the Global Business Unit, where he played a pivotal role in advancing global growth initiatives. A Clear Vision: A strong heritage with a forward-looking vision focused on innovation, operational excellence, and customer value Under Takuya Matsumoto’s leadership, Ushio INE will continue to build on its strong legacy while advancing its mission to deliver high-performance, high-quality lighting solutions across industrial and entertainment markets worldwide. “Our mission is to continuously deliver essential ligh
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 202620.4.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will participate in a panel entitled “Clinical Risk, Regulatory Reality and the Path to Scale” at the Needham Virtual Psychedelics Forum on April 27, 2026, at 11am-12pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable response
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom